SME IPO: Mono Pharmacare issue to open on Monday. 10 things to know about the offer
1) Company overview
The company is engaged in the business of marketing and distributing pharmaceutical products. It works with various contract manufacturers, who make pharmaceutical products based on compositions given by the company, and subsequently it sells those products under the brand «DLS Export».
2) Industry overview
India ranks third worldwide for pharma production by volume and 14th by value.
It is also the largest provider of generic medicines globally, occupying a 20% share in global supply by volume, and is the leading vaccine manufacturer worldwide.
3) Issue size
The IPO is entirely a fresh equity issue of up to 53 lakh shares, aggregating to nearly Rs 15 crore.
4) Price band
The company will offer its shares at a price band of Rs 26-28 apiece, and investors can bid for 4,000 shares in 1 lot.
5) Financial performance
For the period starting October 17, 2022, and ending March, the company has recorded revenues of Rs 33.08 crore and net profit of Rs 94 lakh.
6) Objects of the offer
The net proceeds from the public offer will be used to meet working capital requirements and other general corporate purposes.
7) Book running lead managers
Unistone Capital is acting as the lead manager to the issue, while Bigshare Services is the registrar.
8) Issue structure
About 10% of the offer is reserved for qualified institutional buyers, 45% for non-institutional investors and the rest 45% is set aside for retail investors.
9) Important dates
The IPO opens on August 28 and closes on August 30. The final allotment will likely be made on September 4.
